BACKGROUND: Epidemiologic reports on the effect of microbe exposure on the development of atopy and allergic asthma are inconsistent. OBJECTIVES: The study investigates the association between serologic markers of infections and occurrence of atopy, allergic asthma, and rhinitis among adults in Iceland, Sweden, and Estonia. METHODS: Individuals (n = 1249; mean age, 42 years) from Iceland, Sweden, and Estonia underwent a structured interview and blood sampling. Specific IgE was measured against 4 allergens, and IgG antibodies were measured against Helicobacter pylori, Toxoplasmosis gondii, hepatitis A virus, herpes simplex virus 1, Chlamydia pneumoniae, EBV, and cytomegalovirus. RESULTS: Nonatopic subjects more often had positive serology for Helicobacter pylori, herpes simplex virus 1, Chlamydia pneumoniae, and cytomegalovirus. Having a low number (</=3) of IgG antibodies against the various infectious agents was an independent risk factor for atopy (odds ratio [OR], 1.43; 95% CI, 1.06-1.93), allergic asthma (OR, 1.82; 95% CI, 1.12-2.98), and allergic rhinitis (OR, 1.69; 95% CI, 1.21-2.37). The proportion of atopy that can be explained by a lower number (</=3) of infections was 6.7% in Iceland, 9.2% in Estonia, and 16.4% in Sweden, and 6.7%, 48.2%, and 33.4% for allergic asthma, respectively. CONCLUSION: Our data are consistent with cumulative protective effect of infections against atopy and respiratory allergies irrespective of route of infection. CLINICAL IMPLICATIONS: The study indicates what microbes or combination of microbes play a role in the complex interplay between hygiene and allergy and may contribute toward the understanding of the allergy epidemic.
BACKGROUND: Epidemiologic reports on the effect of microbe exposure on the development of atopy and allergic asthma are inconsistent. OBJECTIVES: The study investigates the association between serologic markers of infections and occurrence of atopy, allergic asthma, and rhinitis among adults in Iceland, Sweden, and Estonia. METHODS: Individuals (n = 1249; mean age, 42 years) from Iceland, Sweden, and Estonia underwent a structured interview and blood sampling. Specific IgE was measured against 4 allergens, and IgG antibodies were measured against Helicobacter pylori, Toxoplasmosis gondii, hepatitis A virus, herpes simplex virus 1, Chlamydia pneumoniae, EBV, and cytomegalovirus. RESULTS: Nonatopic subjects more often had positive serology for Helicobacter pylori, herpes simplex virus 1, Chlamydia pneumoniae, and cytomegalovirus. Having a low number (</=3) of IgG antibodies against the various infectious agents was an independent risk factor for atopy (odds ratio [OR], 1.43; 95% CI, 1.06-1.93), allergic asthma (OR, 1.82; 95% CI, 1.12-2.98), and allergic rhinitis (OR, 1.69; 95% CI, 1.21-2.37). The proportion of atopy that can be explained by a lower number (</=3) of infections was 6.7% in Iceland, 9.2% in Estonia, and 16.4% in Sweden, and 6.7%, 48.2%, and 33.4% for allergic asthma, respectively. CONCLUSION: Our data are consistent with cumulative protective effect of infections against atopy and respiratory allergies irrespective of route of infection. CLINICAL IMPLICATIONS: The study indicates what microbes or combination of microbes play a role in the complex interplay between hygiene and allergy and may contribute toward the understanding of the allergy epidemic.
Authors: Umur Akiner; H Murat Yener; E Deniz Gozen; S Burcu Kuzu; Salih Canakcioglu Journal: Eur Arch Otorhinolaryngol Date: 2019-09-25 Impact factor: 2.503
Authors: Ronald J Fecek; Marisa Marcondes Rezende; Ryan Busch; Ine Hassing; Raymond Pieters; Christopher F Cuff Journal: Immunobiology Date: 2010-03-04 Impact factor: 3.144
Authors: Jorge F C Fernandes; Ernesto A Taketomi; Jose R Mineo; Diego O Miranda; Ronaldo Alves; Rafael O Resende; Leandro H Ynoue; Sun-Sang J Sung; Deise A O Silva Journal: Clin Immunol Date: 2010-03-31 Impact factor: 3.969
Authors: Neuza Maria Alcantara-Neves; Rafael Valente Veiga; Vitor Camilo Cavalcante Dattoli; Rosimeire Leovigildo Fiaccone; Renata Esquivel; Álvaro Augusto Cruz; Philip John Cooper; Laura Cunha Rodrigues; Maurício Lima Barreto Journal: J Allergy Clin Immunol Date: 2011-10-27 Impact factor: 10.793
Authors: Lucia Pacifico; John F Osborn; Valeria Tromba; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa Journal: World J Gastroenterol Date: 2014-02-14 Impact factor: 5.742
Authors: Stephen David Howard Malnick; Ehud Melzer; Malka Attali; Gabriel Duek; Jacob Yahav Journal: World J Gastroenterol Date: 2014-07-21 Impact factor: 5.742